20 research outputs found

    Neuromuscular and Perceptual Responses to Sub-Maximal Eccentric Cycling

    Get PDF
    ObjectiveEccentric (ECC) cycle-ergometers have recently become commercially-available, offering a novel method for rehabilitation training. Many studies have reported that ECC cycling enables the development of higher levels of muscular force at lower cardiorespiratory and metabolic loads, leading to greater force enhancements after a training period. However, fewer studies have focused on the specific perceptual and neuromuscular changes. As the two latter aspects are of major interest in clinical settings, this review aimed to present an overview of the current literature centered on the neuromuscular and perceptual responses to submaximal ECC cycling in comparison to concentric (CON) cycling.DesignNarrative review of the literature.ResultsAt a given mechanical workload, muscle activation is lower in ECC than in CON while the characteristics of the musculo-articular system (i.e., muscle-tendon unit, fascicle, and tendinous tissue length) are quite similar. At a given heart rate or oxygen consumption, ECC cycling training results in greater muscular hypertrophy and strength gains than CON cycling. On the contrary, CON cycling training seems to enhance more markers of muscle aerobic metabolism than ECC cycling performed at the same heart rate intensity. Data concerning perceptual responses, and neuromuscular mechanisms leading to a lower muscle activation (i.e., neural commands from cortex to muscular system) at a given mechanical workload are scarce.ConclusionEven though ECC cycling appears to be a very useful tool for rehabilitation purposes the perceptual and neural commands from cortex to muscular system during exercise need to be further studied

    V̇ o 2peak is of great interest for clinical purposes

    No full text
    International audienc

    Effect of Cycling Cadence on Neuromuscular Function: A Systematic Review of Acute and Chronic Alterations

    No full text
    There is a wide range of cadence available to cyclists to produce power, yet they choose to pedal across a narrow one. While neuromuscular alterations during a pedaling bout at non-preferred cadences were previously reviewed, modifications subsequent to one fatiguing session or training intervention have not been focused on. We performed a systematic literature search of PubMed and Web of Science up to the end of 2020. Thirteen relevant articles were identified, among which eleven focused on fatigability and two on training intervention. Cadences were mainly defined as “low” and “high” compared with a range of freely chosen cadences for given power output. However, the heterogeneity of selected cadences, neuromuscular assessment methodology, and selected population makes the comparison between the studies complicated. Even though cycling at a high cadence and high intensity impaired more neuromuscular function and performance than low-cadence cycling, it remains unclear if cycling cadence plays a role in the onset of fatigue. Research concerning the effect of training at non-preferred cadences on neuromuscular adaptation allows us to encourage the use of various training stimuli but not to say whether a range of cadences favors subsequent neuromuscular performance

    Corticospinal excitability is altered similarly following concentric and eccentric maximal contractions

    No full text
    International audiencePurpose To examine corticospinal excitability and neuromuscular function following the completion of eccentric (ECC) or concentric (CON) maximal exercises of same mechanical work. Methods Ten males (29.9 +/- 11.8 years) performed maximal isokinetic knee extensor contractions in four experimental sessions. The two first sessions (one in ECC and one in CON) ended with a dynamic peak torque loss of 20%. The work completed in each contraction type was then achieved in the other contraction type. Neuromuscular function- maximal voluntary isometric contraction (MVIC), voluntary activation level (VAL), potentiated doublet (Dt), M-wave- and corticospinal excitability- motor evoked potential (MEP) amplitude and silent period (SP)-were assessed in the vastus lateralis (VL) and rectus femoris (RF) muscles at 20% MVIC before and immediately after exercise. Results To lose 20% of dynamic peak torque subjects performed 1.8 times more work in ECC than CON (P = 0.03), inducing a non-different decline in MVIC (P = 0.15). VAL dropped after the ECC sessions only (- 8.5 +/- 6.7%; all P 0.45), irrespective of contraction type (all P > 0.15). Conclusion Same-work maximal ECC and CON exercises induced similar fatigue level but from different origins (preferentially central for ECC vs peripheral for CON). Yet, net corticospinal excitability did not depend on contraction type

    Cartographie des habitats naturels des estrans et zones humides littorales

    No full text
    A l’interface entre terre et mer, les zones humides littorales sont des environnements dont le fonctionnement écosystémique est contraint par les forçages climatiques et anthropiques. Par le biais des directives européennes et des plans de gestion, ces milieux sont suivis et cartographiés à échéance régulière dans le but d’asseoir leur état écologique. Différentes stratégies de cartographie basées sur l’exploitation d’images satellite sont adoptées selon les objectifs à atteindre : (1) cartographie exhaustive des faciès/habitats intertidaux (type Natura 2000), (2) cartographie de l’herbier à Zostera noltii (Directive Cadre sur l’Eau), (3) cartographie des habitats des prés-salés, (4) suivi de l’évolution naturelle des paysages et de la végétation en lien avec des événements accidentels ou volontaires (actions de dépoldérisation)

    Increasing polarity in tacrine and huprine derivatives: Potent anticholinesterase agents for the treatment of myasthenia gravis

    Get PDF
    Symptomatic treatment of myasthenia gravis is based on the use of peripherally-acting acetylcholinesterase (AChE) inhibitors that, in some cases, must be discontinued due to the occurrence of a number of side-effects. Thus, new AChE inhibitors are being developed and investigated for their potential use against this disease. Here, we have explored two alternative approaches to get access to peripherally-acting AChE inhibitors as new agents against myasthenia gravis, by structural modification of the brain permeable anti-Alzheimer AChE inhibitors tacrine, 6-chlorotacrine, and huprine Y. Both quaternization upon methylation of the quinoline nitrogen atom, and tethering of a triazole ring, with, in some cases, the additional incorporation of a polyphenol-like moiety, result in more polar compounds with higher inhibitory activity against human AChE (up to 190-fold) and butyrylcholinesterase (up to 40-fold) than pyridostigmine, the standard drug for symptomatic treatment of myasthenia gravis. The novel compounds are furthermore devoid of brain permeability, thereby emerging as interesting leads against myasthenia gravis

    Increasing polarity in tacrine and huprine derivatives: Potent anticholinesterase agents for the treatment of myasthenia gravis

    No full text
    Symptomatic treatment of myasthenia gravis is based on the use of peripherally-acting acetylcholinesterase (AChE) inhibitors that, in some cases, must be discontinued due to the occurrence of a number of side-effects. Thus, new AChE inhibitors are being developed and investigated for their potential use against this disease. Here, we have explored two alternative approaches to get access to peripherally-acting AChE inhibitors as new agents against myasthenia gravis, by structural modification of the brain permeable anti-Alzheimer AChE inhibitors tacrine, 6-chlorotacrine, and huprine Y. Both quaternization upon methylation of the quinoline nitrogen atom, and tethering of a triazole ring, with, in some cases, the additional incorporation of a polyphenol-like moiety, result in more polar compounds with higher inhibitory activity against human AChE (up to 190-fold) and butyrylcholinesterase (up to 40-fold) than pyridostigmine, the standard drug for symptomatic treatment of myasthenia gravis. The novel compounds are furthermore devoid of brain permeability, thereby emerging as interesting leads against myasthenia gravis
    corecore